{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026349","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2024-07-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.768530+00:00","generated_at":"2026-05-31T23:21:04.042556+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BriaCell receives Nasdaq notice for failing $35M minimum MVLS requirement","bullets":["Received Nasdaq letter on July 3, 2024, for MVLS below $35M for 33 consecutive business days.","Has until December 30, 2024 (180-day compliance period) to regain compliance.","To regain compliance, MVLS must close at $35M+ for at least 10 consecutive business days.","Failure could lead to delisting, with appeal rights to a Nasdaq Hearings Panel.","Listing continues pending compliance; no immediate impact on trading."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026349","json":"https://secwatch.observer/filing/0001493152-24-026349.json","markdown":"https://secwatch.observer/filing/0001493152-24-026349.md","text":"https://secwatch.observer/filing/0001493152-24-026349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/0001493152-24-026349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:21:04.042556+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}